VASCULAR

VBLT NASDAQ
1.180
+0.020
+1.72%
盘后: 1.180 0 0.00% 16:00 08/23 EDT
开盘
1.160
昨收
1.160
最高
1.180
最低
1.159
成交量
1.10万
成交均量(3M)
4.71万
52周最高
1.900
52周最低
0.6000
换手率
0.03%
市值
4,233.97万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供VASCULAR VBLT股票价格,VASCULAR股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of treatments for cancer. The Company's program is based on its Vascular Targeting System (VTS) platform technology, which utilizes genetically targeted therapy to destroy newly formed, or angiogenic, blood vessels. Its lead product candidate, VB-111(ofranergene obadenovec), is a gene-based biologic that it is developing for solid tumor indications, with a program for recurrent glioblastoma (rGBM), a form of brain cancer. It also is engaged in conducting a program focusing anti-inflammatory diseases, based on the use of its Lecinoxoid platform technology. Lecinoxoids are a class of small molecules it developed that are structurally and functionally similar to naturally occurring molecules known to modulate inflammation. The lead product candidate from this program, VB-201, is a Phase II-ready molecule.
展开 >

最近浏览

名称
价格
涨跌幅